$SMTC

New Age Alpha Advisors LLC Takes $310,000 Position in Semtech Corporation $SMTC

New Age Alpha Advisors LLC disclosed in a recent SEC Form 13F that it opened a $310,000 position in Semtech Corp. (NASDAQ:SMTC), buying 4,208 shares in Q4. Other institutions also adjusted holdings, including Ameriprise Financial and Think Investments. The article also cites Semtech’s Q1 results (EPS $0.51 vs. $0.45; revenue $291M vs. $283.53M) and raised analyst price targets.

Original reporting
Published May 29, 2026, 9:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 29, 2026, 10:24 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
New Age Alpha Advisors LLC Takes $310,000 Position in Semtech Corporation $SMTC — source image
Decision brief

The 30-second read

$SMTCBullishMed
01

Why it matters

The combination of a Q1 beat, above-consensus Q2 revenue guidance, and multiple price-target increases can drive momentum trading, while insider selling and negative net margin are potential risk signals.

02

Market read

Institutional buying via 13F plus recent earnings/guidance strength aligns with bullish sentiment, likely supporting continued interest in SMTC.

03

What to watch

The article doesn’t quantify backlog quality or customer concentration; traders should watch for any subsequent revisions to data-center growth assumptions.

Relevance 8/10Novelty 4/10Timing: pre-market/at open today (published 2026-05-29 09:30 UTC)

Background

The piece centers on Semtech’s institutional ownership changes (13F) alongside a recap of recent earnings/guidance and analyst revisions.

Company-level read

Ticker impact

$SMTCBullishMedium confidence
Context

Semtech is the subject of the article: a new 13F position plus detailed Q1 beat, Q2 guidance, and multiple analyst target raises.

Expected impact

Near-term bias to upside/volatility as investors digest guidance/targets; follow-through depends on continued data-center demand.

Evidence & confidence

The article provides concrete, trade-relevant datapoints (Q1 EPS/revenue beat, Q2 revenue guidance, and raised analyst targets) and confirms additional institutional buying via 13F, which typically reinforces sentiment.

Market effects

Positive read-through for analog/mixed-signal and data-center/optical supply chains tied to Semtech’s demand narrative.

Primarily US semiconductor sentiment; could influence NASDAQ small/mid-cap tech flows.

Limited direct global linkage beyond broader data-center capex/optical demand expectations.

Counterpoint

Despite bullish guidance and analyst raises, insiders sold shares and Semtech’s net margin remains negative, which can cap upside if costs or demand normalize.

Key entities

  • Semtech Corporation

    NASDAQ-listed analog/mixed-signal semiconductor supplier; subject of 13F accumulation and recent earnings/guidance/analyst updates.

  • New Age Alpha Advisors LLC

    Reported new 13F position in Semtech valued at ~$310k (4,208 shares).

  • Director Martin Burvill

    Sold 2,500 shares disclosed in SEC filing (Rule 10b5-1).

  • CFO Mark Lin

    Sold 974 shares disclosed in SEC filing (Rule 10b5-1).

Related articles

$SMTCMed

Why Is Semtech (SMTC) Stock Rocketing Higher Today

Semtech (SMTC) shares rose about 5.7% after Needham reiterated a Buy rating and set a $200 price target, citing strong demand and expectations for better performance in 2H 2026 and 2027. Drivers included improved 800G and 1.6T optical module shipments, CopperEdge ACC adoption by a major cloud customer, and LoRa+ wireless demand.

$SMTCMedAI 9/10

Why Semtech (SMTC) Stock Is Trading Up Today

Semtech (NASDAQ:SMTC) shares rose 10.8% in the afternoon, according to the article, after HPE’s Q2 results reinforced demand for AI servers. The report also cites Semtech-related industry signals from Computex 2026, including AMD and Arm rack-scale announcements. Mizuho raised its price target but warned tight memory/CPU supply could limit earnings into 2027.

$ZSHighAI 9/10

Stocks making the biggest moves premarket: Micron, ZScaler, MGM, Bath & Body Works and more

Premarket movers: Zscaler shares fell over 23% after guiding current-quarter revenue to $875M–$878M vs $879M expected, despite fiscal Q3 adjusted EPS of $1.08 beating $1.01 and revenue of $850M beating $835M. Bath & Body Works rose 15% on better guidance; Semtech gained 7% on beats and upside outlook. Micron rose 7% after topping $1T market cap; Sandisk up 3% on Barclays upgrade.

$SMTCHighAI 9/10

Benzinga

Semtech reported first-quarter earnings of 51 cents per share, beating the 45-cent consensus estimate, according to Benzinga Pro data. Revenue was $291 million versus $283.45 million expected, up from $251.1 million a year earlier. Shares rose about 7% to $175.99 in pre-market trading, after the company’s results and second-quarter guidance above estimates.

$SMTCHighAI 9/10

Semtech Corp (SMTC) Q1 2027 Earnings Call Highlights: Record Revenue and Strategic Growth...

Semtech’s Q1 2027 earnings call highlighted record revenue and strategic growth. In Q&A, Hong Hou said ACC MSA specifications are still being finalized and should support faster adoption once aligned. He added Semtech is expanding capacity by doubling or tripling to meet expected Q2 demand, and discussed narrow-linewidth CW lasers for coherent/DWDM and data-center growth tied to 800G FiberEdge/LPO and a ramp toward 1.6T.

$BOXHighAI 9/10

Stocks making the biggest moves after hours: Zscaler, Insulet, Box and more

After-hours movers: Box fell 2% after full-year adjusted EPS guidance of $1.56 vs $1.63 expected, though Q1 adjusted EPS was 37 cents on $306M revenue vs 36 cents and $304M. Zscaler dropped 16% on current-quarter revenue guidance of $875–$878M vs $879M, despite fiscal Q3 EPS of $1.08 and $850M revenue. Semtech rose 8% on Q1 and upbeat guidance; Insulet fell ~9% on a voluntary pod correction tied to insulin under-delivery risk.